These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14651593)

  • 1. Adrenocortical hormones and interleukin patterns in leprosy.
    Leal AM; Magalhães PK; Souza CS; Foss NT
    Parasite Immunol; 2003; 25(8-9):457-61. PubMed ID: 14651593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary-gonadal hormones and interleukin patterns in leprosy.
    Leal AM; Magalhães PK; Souza CS; Foss NT
    Trop Med Int Health; 2006 Sep; 11(9):1416-21. PubMed ID: 16930264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocortical hormones and interleukin patterns in paracoccidioidomycosis.
    Leal AM; Magalhães PK; Martinez R; Moreira AC
    J Infect Dis; 2003 Jan; 187(1):124-7. PubMed ID: 12508155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tumor necrosis factor and interleukin 1 in leprosy and during lepra reactions.
    Parida SK; Grau GE; Zaheer SA; Mukherjee R
    Clin Immunol Immunopathol; 1992 Apr; 63(1):23-7. PubMed ID: 1591878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines in leprosy, I. Serum cytokine profile in leprosy.
    Moubasher AD; Kamel NA; Zedan H; Raheem DD
    Int J Dermatol; 1998 Oct; 37(10):733-40. PubMed ID: 9802682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.
    Sarno EN; Grau GE; Vieira LM; Nery JA
    Clin Exp Immunol; 1991 Apr; 84(1):103-8. PubMed ID: 2015700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in leprosy, II. Effect of treatment on serum cytokines in leprosy.
    Moubasher AD; Kamel NA; Zedan H; Raheem DD
    Int J Dermatol; 1998 Oct; 37(10):741-6. PubMed ID: 9802683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IL-1ra is elevated in lepromatous leprosy patients.
    Fafutis-Morris M; Guillen-Vargas CM; Navarro-Fierro S; Morales-Ortiz R; Armendariz-Borunda J
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):287-91. PubMed ID: 10575408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.
    Goulart IM; Mineo JR; Foss NT
    Clin Exp Immunol; 2000 Dec; 122(3):330-4. PubMed ID: 11122237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lepromatous and tuberculoid leprosy: clinical presentation and cytokine responses.
    Ochoa MT; Valderrama L; Ochoa A; Zea A; Escobar CE; Moreno LH; Falabella R
    Int J Dermatol; 1996 Nov; 35(11):786-90. PubMed ID: 8915730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms.
    Dornelles LN; Pereira-Ferrari L; Messias-Reason I
    Clin Exp Immunol; 2006 Sep; 145(3):463-8. PubMed ID: 16907914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients.
    Makonkawkeyoon S; Kasinrerk W; Supajatura V; Hirunpetcharat C; Vithayasai V
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):311-8. PubMed ID: 1695911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of apoptosis by ionomycin and zinc in peripheral blood mononuclear cells (PBMC) of leprosy patients.
    Gupta A; Sharma VK; Vohra H; Ganguly NK
    Clin Exp Immunol; 1999 Jul; 117(1):56-62. PubMed ID: 10403916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of serum lipids and lipoproteins in leprosy.
    Ahaley SK; Sardeshmukh AS; Suryakar AN; Samson PD
    Indian J Lepr; 1992; 64(1):91-8. PubMed ID: 1573306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of host-protective (IFN-gamma), host-impairing (IL-10, IL-13) and inflammatory (TNF-alpha) cytokines by PBMC from leprosy patients stimulated with mycobacterial antigens.
    Machado P; Abrams J; Santos S; Brennan P; Barral A; Barral-Netto M
    Eur J Dermatol; 1998 Mar; 8(2):98-103. PubMed ID: 9649657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone profile in leprosy.
    Garg R; Agarwal JK; Singh G; Bajpai HS
    Indian J Lepr; 1989 Oct; 61(4):428-31. PubMed ID: 2516097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor: status in reactions in leprosy before and after treatment.
    Bhattacharya SN; Chattopadhaya D; Saha K
    Int J Dermatol; 1993 Jun; 32(6):436-9. PubMed ID: 8320025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumour necrosis factor.
    Straub RH; Lehle K; Herfarth H; Weber M; Falk W; Preuner J; Scholmerich J
    Eur J Endocrinol; 2002 Mar; 146(3):365-74. PubMed ID: 11888843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor (TNF) production in leprosy patients.
    Kaur I; Agnihotri N; Mehta M; Dogra S; Ganguly NK
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):249-50. PubMed ID: 11875771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.